貴州銀行(06199.HK):魏偉峯獲任為聯席公司祕書及法律程序代理人
格隆匯12月27日丨貴州銀行(06199.HK)宣佈,李健強已提呈辭任該行(i)聯席公司祕書及(ii)根據香港聯交所證券上市規則第19A.13(2)條及香港法例第622章公司條例第16部所規定代表該行於香港接收法律程序文件及通知書之代理人(”法律程序代理人“),自2021年12月27日起生效。
董事會進一步宣佈,自2021年12月27日起,魏偉峯獲委任為聯席公司祕書及法律程序代理人,魏偉峯將協助該行聯席公司祕書周貴昌獲得上市規則第3.28條所指的”相關經驗“及履行其作為聯席公司祕書的職責。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.